In last trading session, Candel Therapeutics Inc (NASDAQ:CADL) saw 2.45 million shares changing hands with its beta currently measuring -1.23. Company’s recent per share price level of $10.47 trading at $0.95 or 9.98% at ring of the bell on the day assigns it a market valuation of $465.66M. That closing price of CADL’s stock is at a discount of -39.45% from its 52-week high price of $14.60 and is indicating a premium of 87.2% from its 52-week low price of $1.34.
For Candel Therapeutics Inc (CADL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.19 in the current quarter.
Candel Therapeutics Inc (NASDAQ:CADL) trade information
Upright in the green during last session for gaining 9.98%, in the last five days CADL remained trading in the green while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $10.47 price level, adding 3.77% to its value on the day. Candel Therapeutics Inc’s shares saw a change of 20.62% in year-to-date performance and have moved 26.30% in past 5-day. Candel Therapeutics Inc (NASDAQ:CADL) showed a performance of 57.09% in past 30-days.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -46.75% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -15.27% while estimates for its earnings growth in next 5 years are of -1.01%.
Candel Therapeutics Inc (NASDAQ:CADL)’s Major holders
NORTHPOND VENTURES, LLC is the top institutional holder at CADL for having 1.94 million shares of worth $12.0 million. And as of 2024-06-30, it was holding 6.477 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 0.82 million shares on 2024-06-30. The number of shares represents firm’s hold over 2.819 of outstanding shares, having a total worth of $5.1 million.
